Featured Research

from universities, journals, and other organizations

Navigating the spheres of assisted death

Date:
January 31, 2011
Source:
Canadian Medical Association Journal
Summary:
The issues of assisted death and palliative care in Canada should be discussed in the context of human rights, according to a new commentary.

The issues of assisted death and palliative care in Canada should be discussed in the context of human rights, states a commentary published in CMAJ (Canadian Medical Association Journal).

While the topic of assisted death has been a recent discussion in Canada, we cannot address until the issue of equal access to palliative care has been resolved. In Canada, at least 70% of residents lack access to palliative care and for those who do have access, it is inequitable.

"The equalization of palliative care must occur before legalization of assisted suicide, otherwise, there runs the very real risk that a decision to request assisted death is not fully consenting because of the lack of meaningful choice in the ability to alleviate pain and distress," writes Mary Shariff, Assistant Professor, Faculty of Law, University of Manitoba.

She cites articles 12 the United Nations Universal Declaration of Human Rights, the right to enjoy the highest attainable standard of health as requiring that the scope of the Canadian palliative care system be fully optimized before assisted death is legalized.

"The decisions surrounding our policies on health care must be considered in the broader context of the express commitments and aspirations that we have made as a country. If our tax dollars fall short of providing integrated end-of-life care to all Canadians equally, then our legislators ought to acknowledge and incorporate that fact before moving forward with the legalization of assisted death," concludes the author.


Story Source:

The above story is based on materials provided by Canadian Medical Association Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. Mary J. Shariff. Navigating assisted death and end-of-life care. Canadian Medical Association Journal, 2011; DOI: 10.1503/cmaj.091845

Cite This Page:

Canadian Medical Association Journal. "Navigating the spheres of assisted death." ScienceDaily. ScienceDaily, 31 January 2011. <www.sciencedaily.com/releases/2011/01/110131132953.htm>.
Canadian Medical Association Journal. (2011, January 31). Navigating the spheres of assisted death. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/01/110131132953.htm
Canadian Medical Association Journal. "Navigating the spheres of assisted death." ScienceDaily. www.sciencedaily.com/releases/2011/01/110131132953.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins